You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Antibiotics in the clinical pipeline in 2011
|
|---|---|
| Published in |
The Journal of Antibiotics, May 2011
|
| DOI | 10.1038/ja.2011.44 |
| Pubmed ID | |
| Authors |
Mark S Butler, Matthew A Cooper |
| Abstract |
The emergence of multi-drug-resistant bacteria and the lack of new antibiotics in the antibiotic drug development pipeline, especially those with new modes of action, is a major health concern. This review lists the 20 new antibiotics launched since 2000 and records the 40 compounds currently in active clinical development. Compounds in the pipeline from new antibiotic classes are reviewed in detail with reference to their development status, mode of action, spectrum of activity and lead discovery. In addition, the NP or synthetic derivation is discussed, with activity against Gram-negative bacteria highlighted. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Kuwait | 1 | 50% |
| Germany | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 307 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 5 | 2% |
| India | 3 | <1% |
| Germany | 2 | <1% |
| United States | 2 | <1% |
| China | 2 | <1% |
| Belgium | 2 | <1% |
| Brazil | 1 | <1% |
| Indonesia | 1 | <1% |
| Italy | 1 | <1% |
| Other | 10 | 3% |
| Unknown | 278 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 76 | 25% |
| Researcher | 59 | 19% |
| Student > Master | 45 | 15% |
| Student > Bachelor | 24 | 8% |
| Student > Postgraduate | 16 | 5% |
| Other | 53 | 17% |
| Unknown | 34 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 117 | 38% |
| Chemistry | 58 | 19% |
| Biochemistry, Genetics and Molecular Biology | 29 | 9% |
| Medicine and Dentistry | 27 | 9% |
| Immunology and Microbiology | 14 | 5% |
| Other | 26 | 8% |
| Unknown | 36 | 12% |
Attention Score in Context
This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2023.
All research outputs
#851,204
of 24,323,943 outputs
Outputs from The Journal of Antibiotics
#24
of 3,829 outputs
Outputs of similar age
#3,083
of 115,224 outputs
Outputs of similar age from The Journal of Antibiotics
#2
of 5 outputs
Altmetric has tracked 24,323,943 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,829 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 115,224 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.